Chitnis S V, Chitnis V, Sharma N, Chitnis D S
Department of Microbiology and Immunology, Choithram Hospital and Research Centre, Indore.
J Assoc Physicians India. 2003 Jan;51:28-32.
To study the prevalence of drug resistance among gram-negative bacilli and susceptibility to the Cefoperazone + Sulbactam and Piperacillin + Tazobactam combination among the hospital isolates resistant to all other antimicrobial agents.
A total of 367 gram-negative bacilli isolated from various pathological samples were tested for susceptibility to antimicrobial agent by the disc diffusion technique and 300 isolates of gram-negative bacilli which were resistant to all the other antibiotics were checked for sensitivity to piperacillin + tazobactam and cefoperazone + sulbactam combination.
Resistance to ampicillin and amoxicillin + clavulanic acid ranged from (72.1-83.8%) which was highest. Resistance to cotrimoxazole, gentamicin, netilmycin, quinolones and all the generation of cephalsporins was often above 50%. piperacillin + tazobactam combination had the lowest incidence of resistance (14 to 20.5%).
Drug resistance for most of the antimicrobial agents was greater than 50% including the various generations of cephalosporins. Inefficiency of amoxicillin + clavulanic acid (resistance among 72-79.5% isolates) suggests the presence of extended spectrum beta-lactamases among the isolates. Addition of sulbactam to cefoperazone showed increased activity (resistance 27 to 34%) but piperacillin + tazobactam was the most effective combination in vitro.
研究革兰氏阴性杆菌的耐药率,以及对所有其他抗菌药物耐药的医院分离株对头孢哌酮+舒巴坦和哌拉西林+他唑巴坦联合用药的敏感性。
采用纸片扩散法对从各种病理样本中分离出的367株革兰氏阴性杆菌进行抗菌药物敏感性测试,并对300株对所有其他抗生素耐药的革兰氏阴性杆菌分离株检测其对哌拉西林+他唑巴坦和头孢哌酮+舒巴坦联合用药的敏感性。
对氨苄西林和阿莫西林+克拉维酸的耐药率在(72.1 - 83.8%)之间,为最高。对复方新诺明、庆大霉素、奈替米星、喹诺酮类以及所有代头孢菌素的耐药率通常高于50%。哌拉西林+他唑巴坦联合用药的耐药率最低(14%至20.5%)。
包括各代头孢菌素在内的大多数抗菌药物的耐药率超过50%。阿莫西林+克拉维酸无效(72 - 79.5%的分离株耐药)表明分离株中存在超广谱β-内酰胺酶。头孢哌酮加用舒巴坦显示活性增加(耐药率27%至34%),但哌拉西林+他唑巴坦在体外是最有效的联合用药。